Copyright Staten Island Advance
More than 141,000 bottles of a common cholesterol medication distributed nationwide have been recalled, according to the U.S. Food and Drug Administration. The recall involves bottles of Atorvastatin Calcium Tablets sold in 10 mg, 20 mg, 40 mg, and 80 mg. They were sold in 90-count, 500-count, and 1,000-count bottles with expiration dates as late as February 2027. Ascend Laboratories, LLC initiated the recall due to failed dissolution specifications, which means the drugs may not dissolve properly in the body once it’s swallowed. The bottles of medication were distributed nationwide. The recall was initiated on Sept. 19, and was classified to a Class II risk level on Oct. 10. A Class II recall is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. The recall remains ongoing, according to the U.S. Food and Drug Administration report.
